January 30, 2015 2:21 PM ET

Pharmaceuticals

Company Overview of Oncopeptides AB

Company Overview

Oncopeptides AB is a clinical stage pharmaceutical development company that develops cytosuperior chemotherapeutic pharmaceuticals of existing basic cytotoxic compounds for cancer treatment. Its product includes Melflufen, a cytosuperior of the chemotherapeutic alkylator melphalan that is accumulated in cancer cells for targeting multiple myeloma. The company is headquartered in Stockholm, Sweden.

Västra Trädgårdsgatan 15

Stockholm,  111 53

Sweden

Phone:

46 7 05 69 54 71

Key Executives for Oncopeptides AB

Chief Executive Officer
Age: 42
Compensation as of Fiscal Year 2014.

Oncopeptides AB Key Developments

Oncopeptides AB Presents at BIO-Europe 2014, Nov-05-2014 09:30 AM

Oncopeptides AB Presents at BIO-Europe 2014, Nov-05-2014 09:30 AM. Venue: Portalhaus Messe Frankfurt, Strasse der Nationen, 60327 Frankfurt, Germany.

Oncopeptides AB Presents at BioEquity Europe 2014, May-22-2014 09:40 AM

Oncopeptides AB Presents at BioEquity Europe 2014, May-22-2014 09:40 AM. Venue: Hilton Amsterdam Hotel, Amsterdam, Netherlands.

Similar Private Companies By Industry

Company Name Region
Mylan AB Europe
Meda OTC AB Europe
Boehringer Ingelheim AB Europe
Roche AB Europe
NeuroNova AB Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oncopeptides AB, please visit www.oncopeptides.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.